Compounding Animal Drugs From Bulk Drug Substances; Draft Guidance for Industry; Availability; Reopening of Comment Period

摘要

The Food and Drug Administration (FDA or the Agency) is reopening the comment period for the notice of availability that published in the Federal Register on November 20, 2019. In that notice, FDA requested comments on the draft guidance for industry (GFI) #256 entitled "Compounding Animal Drugs from Bulk Drug Substances." FDA is reopening the comment period to update comments and to receive any new information.